Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn Velligan

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Schizophrenia Research|January 21, 2012
Motivational intervention increases exercise in schizophrenia and co-occurring substance use disordersLora Humphrey Beebe, Kathleen Smith, Renee Burk, et al.
Clinical Schizophrenia & Related Psychoses|November 23, 2017
Relapse Risk Assessment for Schizophrenia Patients (RASP): A New Self-Report Screening ToolDawn Velligan, William Carpenter, Heidi C Waters, et al.
Schizophrenia Research. Cognition|December 14, 2019
A comparison of compensatory and restorative cognitive interventions in early psychosisSean A Kidd, Yarissa Herman, Gursharan Virdee, et al.
Schizophrenia Bulletin Open|March 20, 2025
Preferences for Selecting and Initiating Long-Acting Injectable Antipsychotic Agents for the Treatment of Patients With Schizophrenia: Results From the US DECIDE SurveyDawn Velligan, Gregory D Salinas, Emily Belcher, et al.
BMC Psychiatry|March 12, 2025
Clinician differences in attitudes and perceptions on the use of long-acting injectable antipsychotic agents in treating patients with schizophrenia: results from the US DECIDE surveyDawn Velligan, Gregory D Salinas, Emily Belcher, et al.
Community Mental Health Journal|November 30, 2010
Effect of a motivational intervention on exercise behavior in persons with schizophrenia spectrum disordersLora Humphrey Beebe, Kathy Smith, Renee Burk, et al.
Schizophrenia Research|November 18, 2011
Assessment of the effects of AZD3480 on cognitive function in patients with schizophreniaDawn Velligan, Ronald Brenner, Franco Sicuro, et al.
Schizophrenia Research|November 12, 2013
Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathwayDimitre H Dimitrov, Shuko Lee, Jesse Yantis, et al.
The International Journal of Neuropsychopharmacology|February 26, 2014
Metabolomic profiling of schizophrenia patients at risk for metabolic syndromeR Madelaine Paredes, Marlon Quinones, Ketan Marballi, et al.
Psychiatric Research and Clinical Practice|October 18, 2022
Mental Health Care Provider's Perspectives Toward Adopting a Novel Technology to Improve Medication AdherenceJoshua N Liberman, Tigwa Davis, Dawn Velligan, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Schizophrenia Research|January 21, 2012
Motivational intervention increases exercise in schizophrenia and co-occurring substance use disordersLora Humphrey Beebe, Kathleen Smith, Renee Burk, et al.
Clinical Schizophrenia & Related Psychoses|November 23, 2017
Relapse Risk Assessment for Schizophrenia Patients (RASP): A New Self-Report Screening ToolDawn Velligan, William Carpenter, Heidi C Waters, et al.
Schizophrenia Research. Cognition|December 14, 2019
A comparison of compensatory and restorative cognitive interventions in early psychosisSean A Kidd, Yarissa Herman, Gursharan Virdee, et al.
Schizophrenia Bulletin Open|March 20, 2025
Preferences for Selecting and Initiating Long-Acting Injectable Antipsychotic Agents for the Treatment of Patients With Schizophrenia: Results From the US DECIDE SurveyDawn Velligan, Gregory D Salinas, Emily Belcher, et al.
BMC Psychiatry|March 12, 2025
Clinician differences in attitudes and perceptions on the use of long-acting injectable antipsychotic agents in treating patients with schizophrenia: results from the US DECIDE surveyDawn Velligan, Gregory D Salinas, Emily Belcher, et al.
Community Mental Health Journal|November 30, 2010
Effect of a motivational intervention on exercise behavior in persons with schizophrenia spectrum disordersLora Humphrey Beebe, Kathy Smith, Renee Burk, et al.
Schizophrenia Research|November 18, 2011
Assessment of the effects of AZD3480 on cognitive function in patients with schizophreniaDawn Velligan, Ronald Brenner, Franco Sicuro, et al.
Schizophrenia Research|November 12, 2013
Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathwayDimitre H Dimitrov, Shuko Lee, Jesse Yantis, et al.
The International Journal of Neuropsychopharmacology|February 26, 2014
Metabolomic profiling of schizophrenia patients at risk for metabolic syndromeR Madelaine Paredes, Marlon Quinones, Ketan Marballi, et al.
Psychiatric Research and Clinical Practice|October 18, 2022
Mental Health Care Provider's Perspectives Toward Adopting a Novel Technology to Improve Medication AdherenceJoshua N Liberman, Tigwa Davis, Dawn Velligan, et al.
Pageof 4